According to MarketsandMarkets™, the global Low Voltage DC Circuit Breaker Market size is projected to grow from USD 1.80 billion in 2025 to USD 2.52 billion by 2030 at a compound annual growth rate ...
3d
Collaborative Robot: Global Market Trends and Investment Opportunities Till 2033 | Astute Analytica
The global collaborative robot (cobot) market growth is fueled by industries’ urgent need for automation that complements ...
The 24-hour countdown for the launch of LVM3-M6 rocket, which will carry a new generation U.S. communication satellite commenced in Sriharikota on Tuesday (December 23, 2025), ISRO said. In a ...
ISRO's upcoming LVM3 M6 mission will carry the BlueBird Block-2 satellite into orbit on December 24, as part of a commercial deal with U.S.-based AST SpaceMobile. The historic mission will deploy the ...
Figure 1: NICT's 7.4 km, 2 Tbit/s horizontal propagation experiment (April 2025). The ST terminal was used as the transmitter and the FX terminal as the receiver. The terminals exchanged pseudo-random ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. All doses of orforglipron conferred greater decreases in ...
What Is Kygevvi, and Why Does It Matter? Kygevvi is a new oral medicine for people with thymidine kinase 2 deficiency (TK2d), an extremely rare genetic condition affecting the muscles. The FDA has ...
Clinical responses observed in 93 percent of patients at just four weeks in either FricTest Score or Pruritus-NRS, with improvements seen as early as week one Favorable safety and tolerability profile ...
While companies invest heavily in benefits, leadership development and engagement programs, they consistently overlook the foundational behavior that determines whether those investments succeed or ...
As the oral GLP-1 race intensifies, Eli Lilly has slimmed back the number of phase 2 trials it is conducting for one of its contenders. The Big Pharma had been running three midstage studies of the ...
The modules have been verified by TÜV Rheinland as having 91.7% bifaciality. Tongwei is also one of only two companies in the global top 10 to earn maximum ratings across all categories of the 2025 ...
Eli Lilly is releasing new Phase 3 trial results Tuesday. Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose approximately 23 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results